Uncategorized

BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot

Published

4 days ago

on

BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology continues to face headwinds in the U.S.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version